The American Association of Pharmaceutical Sientists (AAPS) meeting in Atlanta saw presentations and product launches from a wide range of firms operating in the outsourcing and drug manufacturing sectors.
The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing process can be much more problematic. in-PharmaTechnologist spoke with McCrone Associates' Heidi Ullberg at this year's AAPS in Atlanta about a light microscopy that can help drugmakers address this problem.
American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20.